Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Tax Payment
Common Stock
2024-05-31$0.35/sh−1,396$489→ 83,024 total
Footnotes (2)
- [F1]1,396 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
- [F2]Includes 5,000 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2024.